Diagnostic challenges in isolated cardiac sarcoidosis
ESC Heart Failure · 05.05.2026 · 13 (3)
DOI: 10.1093/eschf/xvag159 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift ESC Heart Failure, online erschienen am 03.06.2026. Verfasst von Gregorio Tersalvi und 15 weiteren Autor:innen. Beteiligte Einrichtung: Department of Cardiovascular Medicine, Mayo Clinic, Rochester, MN, USA. Hauptthemen laut MEDLINE: Sarcoidosis, Cardiomyopathies, Multimodal Imaging, Myocardium. Die Arbeit nennt 114 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).
Abstract (Originalsprache)
Isolated cardiac sarcoidosis (iCS), defined by granulomatous inflammation limited to the myocardium, represents the most diagnostically challenging and prognostically adverse form of sarcoidosis. As it is fundamentally a diagnosis of exclusion, iCS diagnosis relies on the absence of extracardiac sarcoid and the integration of multimodality imaging, endomyocardial biopsy, and molecular testing, each with inherent limitations. Cardiac magnetic resonance and positron emission tomography provide complementary assessment of inflammation, fibrosis, and ventricular function, enhancing diagnostic confidence. Electroanatomic mapping-guided biopsy may improve histologic yield, whereas genetic testing helps exclude phenocopies such as arrhythmogenic, hypertrophic, or dilated cardiomyopathies. Circulating biomarkers remain non-specific but may complement imaging-based algorithms. Future research should focus on harmonized imaging protocols, non-FDG radiotracers, and molecular tissue profiling to refine activity assessment and guide therapy. Multimodal, probability-based frameworks represent the most promising approach for earlier, more accurate diagnosis and risk stratification in iCS.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Cardiovascular Medicine, Mayo Clinic, Rochester, MN, USA.
- University Heart Center, University Hospital of Zurich, Zurich, Switzerland.
- Department of Cardiology, Inselspital, Bern University Hospital, University of Bern, Bern, Switzerland.
- Department of Cardiology, Cardiocentro Ticino Institute, Ente Ospedaliero Cantonale, Lugano, Switzerland.
- Department of Internal Medicine, Ente Ospedaliero Cantonale, Bellinzona, Switzerland.
- Deutsches Herzzentrum der Charité, Department of Cardiology, Angiology and Intensive Care Medicine, Campus Virchow Klinikum, Berlin, Germany.
ORCID-Profile: Gregorio Tersalvi, Giorgio Treglia, Heinz-Peter Schultheiss, Kurt Huber, Gerhard Pölzl, Omar F AbouEzzeddine, Martin R Grübler
Zitieren
APA
Tersalvi, G., Rossi, V. A., Hundertmark, M., Beltrani, V., Escher, F., Wörgötter, K., Dobner, S., Thianich, F. C., Treglia, G., Schultheiss, H. P., Huber, K., Martinelli, M., Pölzl, G., Rosenbaum, A. N., AbouEzzeddine, O. F., & Grübler, M. R. (2026). Diagnostic challenges in isolated cardiac sarcoidosis. ESC Heart Failure, 13(3). https://doi.org/10.1093/eschf/xvag159
Vancouver
Tersalvi G, Rossi VA, Hundertmark M, Beltrani V, Escher F, Wörgötter K, et al. Diagnostic challenges in isolated cardiac sarcoidosis. ESC Heart Failure. 2026;13(3). doi:10.1093/eschf/xvag159
BibTeX
@article{Tersalvi2026,
author = {Tersalvi, Gregorio and Rossi, Valentina A and Hundertmark, Moritz and Beltrani, Vittorio and Escher, Felicitas and Wörgötter, Katharina and Dobner, Stephan and Thianich, Felicia C and Treglia, Giorgio and Schultheiss, Heinz-Peter and Huber, Kurt and Martinelli, Michele and Pölzl, Gerhard and Rosenbaum, Andrew N and AbouEzzeddine, Omar F and Grübler, Martin R},
title = {Diagnostic challenges in isolated cardiac sarcoidosis},
journal = {ESC Heart Failure},
year = {2026},
volume = {13},
number = {3},
doi = {10.1093/eschf/xvag159}
}
EUVIMED